Abstract Eight Icelandic breast cancer kindreds were subjected to linkage analyses with respect to 28 microsatellite loci dispersed along the short arm of chromosome 3. Breast tumors derived from these kindreds were concurrently scored for allelic imbalance with ten of the markers. Linkage to most markers could be excluded on the basis of negative LOD scores and haplotype analyses, although some moderately positive LOD scores resulted. A high frequency of imbalance in the familial tumors was seen with two of the markers in comparison with results obtained from sporadic material. The highest frequency (68%) of imbalance was detected with the marker D3S 1217, which is located on 3p 14.2-p 14.1. Imbalance at the D3S1211 locus, which is more telomeric (3p24.2-p22), was not significantly elevated in the familial tumors. We suggest that the genetic defect responsible for breast cancer susceptibility in these families either promotes instability in the 3p14.2-p 14.1 region or enhances the selective advantage of such changes.
Introduction
Epidemiological evidence suggests that the risk of an individual developing breast cancer is increased significantly when the disease is manifested in close relatives (Claus et al. 1991) . The risk for relatives of breast cancer patients is further increased with decreasing age at onset and bilateral disease of the probands. Hence, these two factors serve as indicators of genetic susceptibility. The segregation of breast cancer in high risk families is best explained by assuming an underlying autosomal dominant gene defect and incomplete penetrance (Newman et al. 1988) .
Genetic linkage studies have localized a gene predisposing individuals to this disease to a region of chromo-J. T. Bergthorsson -G. Eiriksdottir 9 R. B. Barkardottir V. Egilsson 9 A. Arason 9 S. Ingvarsson (tg~) Department of Pathology, National University Hospital Box 1465, IS-121 Reykjavl"k, Iceland some 17q (Hall et al. 1990 ). This gene, termed BRCA1, is probably responsible for a high fraction of familial breast and ovarian cancers , and loss of heterozygosity at this site in familial tumors suggests that it is a tumor suppressor gene . Germline mutations in a strong candidate gene for BRCA1 have been described in affected families . A second region of linkage in hereditary breast cancer has been localized on chromosome 13q12-13 (Wooster et al. 1994) . Breast cancer kindreds showing linkage to this region, which is referred to as BRCA2, are characterized by early onset breast cancer, but they differ from the 17q-linked kindreds in that no excess of ovarian cancer is found. Genetic heterogeneity with respect to 17q and 13q linkage is apparent, and therefore it is likely that genes other than BRCA1 and BRCA2 contribute to familial breast cancer.
Several other genes have been implicated in the onset of breast cancer. Mutations in the P53 gene are responsible for various types of malignancies, including breast cancer, in families affected by the Li-Fraumeni syndrome (Srivastava et al. 1990; Prosser et al. 1992) . The androgen receptor is implicated in genetic predisposition to male breast cancer (Wooster et al. 1992) . Individuals who are heterozygotes with respect to the ataxia telangiectasia locus have an elevated risk of developing breast cancer, although this locus appears to be unimportant in familial breast cancer (Wooster et al. 1993) . Other candidate loci are regions frequently carrying genetic lesions in sporadic breast tumors or sites of genes that are known to be important in breast cancer tumorigenesis. These include regions of frequent loss of heterozygosity in breast tumors; lq, 3p, 6q, 9q, llp, 16q, 18q (Devilee et al. 1991; Cornelisse et al. 1992) .
Deletions of the short arm of chomosome 3 have been described in human cancers at various sites, including kidney (Kovacs et al. 1988) , lung (Hibi et al. 1992) , ovary (Ehlen and Dubeau 1990), testis (Lothe et al. 1989) , cervix (Yokota et al. 1989) , head and neck (Latif et al. 1992) , nasopharynx , and breast (Sato et al. 1991) . These findings indicate the presence of one or more tumor suppressor genes on 3p. Further support for this is provided by the results of a functional study, in which a small fragment of chromosome 3 (p21-p22) suppressed growth of a highly malignant fibrosarcoma cell line in athymic mice (Killary et al. 1992) . Pandis et al. (1993) have reported an interstitial deletion (del (3)(p12p14)) in four short-term cultures of breast tumors that appear to be clonal. This is the only aberration present in three of the tumors, suggesting that 3p12-14 deletions may be a primary event in the malignant transformation of the breast.
The aim of this study was to evaluate the significance of the short arm of chromosome 3 in familial breast cancer. This was achieved by linkage analyses of eight breast cancer kindreds, by means of 3p microsatellite markers, and by assessment of allelic imbalance in the familial tumors.
Materials and methods

Families
Eight unrelated breast cancer kindreds were included in this study with a total of 64 breast cancer patients (eight bilateral cases, four breast-ovary cases, and one male breast cancer) and 41 individuals diagnosed with cancer at other sites (Table 1 ). The mean age at onset of breast cancer in the kindreds ranged from 43 to 53 years. One of the eight kindreds in this study (FAM-1) has previously been shown to be linked to the BRCA1 locus (Arason et al. 1993) . Cancer in organs other than the breast is noticeable in some of the families, in particular, prostate cancer, which has recently gained attention as a possible risk factor associated with inherited breast cancer susceptibility. Information regarding family members and pedigree structure was obtained from the Icelandic Genealogy Commitee, the Icelandic Cancer Registry, pathology records, and death certificates obtained from the Statistical Bureau of Iceland. Samples DNA was prepared from whole blood and tumor samples by conventional phenol-extraction methods (Sambrook et al. 1989) . Paraffin-embedded tissue of tumor and normal samples was also collected and prepared for polymerase chain reaction (PCR) analysis by the methods described by Smith et al. (1992) and Jackson et al. (1990) . 
Markers
The 29 markers used in this study are listed in Table 2 . They are all localized on 3p, except for D3S1237, which maps to the long arm of the chromosome. The order of marker loci on the chromosome was compiled from the G6ndthon linkage map (Gyapay et al. 1994) , linkage maps available from the GDB (Genome Data Base, The Johns Hopkins University, Baltimore, Maryland, USA) (C3M60), and the GDB physical map assignment. The interval between the 3p markers included in the G6ndthon linkage map ranged lu 8 13 cM, but reached 27 cM in one case (between D3S1263 and D3S1297) near the telomere.
PCR analysis
PCR was carried out in a volume of 30 ~l containing 3-10 pmol of each primer, 0.2 mM of each dNTP, 0.5-1 ~tl (protease-melted) or 50 ng (phenol-extracted) template DNA, 0.3 units thermostable DNA polymerase (Finnzymes Oy), and buffer supplied with the enzyme. One primer in the reaction mixture was end-labeled with yATP 32 using T4 polynucleotide kinase (Amersham). Samples were processed through 35 cycles comprising 1 min at 94~ 1 min at the appropriate annealing temperature, and 2 min at 72~ in a Techne PHC-3 thermocycler. Aliquots of the amplified DNA were electrophoresed on standard denaturing 6% polyacrylamide DNA sequencing gels that were exposed to an X-ray film. Standardization within and between gels was achieved by using a mixture of 3 or 4 amplified samples that produced a ladder, preferably containing the smallest and largest bands of the allele spectrum.
Linkage analysis
Two-point linkage analysis was performed using the MLINK program (version 5.03) of the LINKAGE program package (Lathrop and Lalouel 1984) . LOD scores were calculated by the assumption of an autosomal dominant disease allele with a frequency of 0.001. Incomplete penetrance was assumed and individuals were assigned to 14 different liability classes on the basis of sex, age, and disease status in accordance with the model constructed for BRCAI by Easton et al. (1993) . Individuals with cancer in organs other than breast were regarded as unaffected in the calculations. Allele frequencies for all marker alleles were initially set as being equal. However, moderately positive LOD scores (> 0.5, at 0 = 0) were recalculated using observed or published allele frequencies, and examination of haplotypes with adjacent markers was also applied whenever a given marker produced LOD scores that exceeded this limit. Linkage analysis in one kindred (FAM-5) is greatly complicated by three apparent consanguinity loops. LOD scores for this family were therefore calculated separately for the two main branches, thereby reducing the number of marriage loops to one. Five breast cancer patients reside in one branch, six in the other and three of these are shared by both branches.
Allelic imbalance
Allelic imbalance in tumors from family members was assessed with eleven markers; D3S1307, D3S1297, D3S1263, D3S656, D3S1211, D3S1289, D3S1029, D3S1285, D3S1217, D3S1284, and D3S1237. Some 35 paired normal and breast tumor samples from seven of the kindreds were availible for analysis. The data were compared with the results obtained in a study on sporadic material (Eirfksd6ttir et al. 1995) for markers D3S 1217, D3S 1029, and D3S 1211, which were shared in the two studies.
Results
LOD scores for the markers calculated at zero recombination to disease loci are presented in Table 3 . The sum of Table 2 Microsatellite markers used. Distances between markers were obtained from Gyapay et al. (1994 LOD scores for singular markers over all kindreds ranged from-10.664 (D3S1067) to 0.886 (D3S1270). No significant LOD scores were found in any single kindred, and the highest value was found with the marker located on 3q in kindred 2. This region was examined further by applying four additional markers (RHO, D3S196, GLUT2, D3S1232), which all produced negative LOD scores. Application of haplotype analysis also strengthened arguments against 3q linkage in kindred 2.
Haplotype analyses with markers adjacent to those that produced positive results (LOD > 0.5) ruled out the possibility of true linkage of 3p loci with the disease in all the kindreds except families 5B and 7. In family 7, a LOD score of 0.647 was gained with the marker D3S 1285. This LOD score was reduced to 0.487 when it was recalculated using allele frequencies obtained from GDB. Haplotypes constructed with the surrounding markers (from D3S 1312 to D3S 1210) did not exclude linkage. Allelic imbalance is apparent in the tumor material of siblings (nos. 1 and 2: FAM-7; Fig. 1 ) in this family. If these are assumed to be deletions, then the remaining alleles have a different parental origin.
A moderate LOD score is found in the right branch of family 5 (FAM-5B) in a region spanning D3S1228 to D3S1210. The highest LOD score in this area is given by the marker D3S1217, and this remains unchanged when recalculated with allele frequencies derived from the genotypes of 30 healthy unrelated individuals. The same haplotype is shared in four breast cancer patients, two ovary patients and one breast-ovary cancer patient. In the same branch, two individuals diagnosed with cervical cancer in situ, one with invasive cervical cancer, do not have the haplotype in question. Imbalance is not consistent with linkage, as one of the three tumors (no. 2: FAM-5; Fig. 1 ) from this kindred, which showed imbalance, had reduced intensity of the founder alleles.
Allelic imbalance with one or more markers on 3p was seen in 26 of the 35 tumors available (see Fig. 1 ) for analyses. The marker D3S1217 was most frequently involved, as 17 of 25 informative samples showed imbalance at this site. The frequency of imbalance with individual markers progressively increased with proximity to this locus, being lowest near the telomere (D3S1307, D3S 1297). We compared, by Chi-square analysis, the imbalance in the familial tumors with results obtained from sporadic material for the marker loci D3S1217, D3S1029, and D3S1211 (Table 4) . Excess imbalance in the familial tumors was evident with the markers D3S1217 and D3S 1029. The number of cases with imbalance in the re- Of the 26 samples, 8 showed imbalance with only one marker, and the remaining 18 had imbalance at two or more loci. The alleles in cases where 3p imbalance was evident could frequently be given parental assignments. No bias with regard to the origin (parental assignment) of these alleles was detected with any marker. In 14 cases, the derivation of the alleles was known for at least two loci showing imbalance. In two of these, the alleles with reduced intensity were not derived from the same parental chromosome. In sample 1 (FAM-1), signal reduction of the maternal allele is evident with the marker D3S 1263, whereas paternal alleles are reduced in the four remaining loci where imbalance is seen (Fig. 2) . This is also evident in sample 2 (FAM-4) where signal reduction of the paternal allele is evident with the marker D3S 1217, whereas the maternal signal is reduced in the remaining imbalanced loci (not shown).
Discussion
Strong evidence of genetic linkage to loci on the short arm of chromosome 3 was not found in any of the eight breast cancer kindreds. Two kindreds could not be excluded from linkage on the basis of LOD scores or haplotype analysis. A common region of linkage in these was at the D3S 1285 loci. Allelic imbalance in tumors from these kindreds showed that the alleles with retained intensity were not confined to those segragating with the disease, as would be expected if Knudson's two-hit theory for tumor suppressor genes applied. It is unlikely that a germline mutation in a tumor suppressor gene, predisposing to breast cancer, resides at 3p loci in the eight kindreds tested for linkage.
Allelic imbalance of at least one of the 11 marker loci has been detected in 26 of the 35 familial tumors (74%). In comparison with sporadic material, imbalance in familial tumors appears at a significantly higher frequency at the D3S1217 and D3S1029 loci, but not at D3S1211. This is independent of the source of material, as the frequency of imbalance is not statistically different between tumors prepared from fresh tissue or paraffin slices.
Difference in the frequency of allelic imbalance between sporadic and familial tumors appears to be contributed by the D3S 1217 locus. Although weak statistical significance is also gained with D3S1029, allelic imbalance at this locus is highly dependent upon AI with D3S1217. As seen in Fig. 1 , all the samples with imbalance at either D3S 1029 or D3S 1289 also display AI at the D3S1217 locus or are uninformative. Further, the frequency of imbalance observed with D3S1029 is not significantly higher in the familial tumors when kindred 1 is disregarded. Imbalance at more telomeric loci, viz., D3S121 l, D3S656 and D3S1263, appear with no association of AI at D3S 1217, and may consequently represent a second region of 3p instability.
Imbalance on 3p is found in tumors from all kindreds, including the 17q linked kindred (FAM-1). All the tumors that are informative for D3S1217 in kindred 1 have imbalance, and of the two remaining, one shows AI with the adjacent marker D3S1284. Thus, the breast cancer kindreds are homogeneous with respect to instability at 3p14, although they appear to be heterogeneous with respect to 17q linkage and tumor spectrum (Table 1) .
Imbalance in 12 of 14 tumors involved signal reduction of alleles from the same parental chromosome. This was also true for the 4 tumors in which the imbalance was not continual. In two cases, the imbalance affected different parental alleles. These two cases could either reflect a different kind of instability on the same chromosome (amplifications and deletions), or the same type of instability affecting different parental chromosomes.
The observed instability at the 3p14 region in familial tumors can be explained by at least two hypotheses. First, this region could carry a tumor supressor gene that is more often deleted in the familial tumors, because the sequence of molecular changes leading to malignant growth in familial tumors especially depends on a cooperative effect of a germline mutation and the 3p deletion. Secondly, a germline mutation segregating with the disease in these families may promote genetic instability at specific sites, and the excess of imbalance in familial tumors would therefore be explained by a combination of selection and increased likelihood of the chromosomal change leading to imbalance. In this respect, the physical assignment of D3S1217 to 3p14.2-p14.1 implies proximity to FRA3B, one of the most fragile sites known in the human genome (Wilkie et al. 1994) . Chromosomal breaks at this site are induced by aphidicolin, which disturbs the DNA replication process.
The results presented here suggest a distinction between sporadic and familial breast cancer on a molecular basis. Further support of this is offered by the observed elevated frequency of P53 mutations in familial breast tumors (Glebov et al. 1994 ) and recent findings concerning the BRCA1 gene. Germline mutations in BRCA1 are found in association with a positive history of breast cancer, but somatic changes in the gene have not been described . Extended knowledge of the function and specificity of the BRCAI gene product should help to resolve these problems.
